Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
26,522,848
-
Share change
-
-4,153,631
-
Total reported value
-
$118,815,139
-
Price per share
-
$4.48
-
Number of holders
-
42
-
Value change
-
-$20,551,229
-
Number of buys
-
21
-
Number of sells
-
32
Institutional Holders of STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) as of Q4 2018
As of 31 Dec 2018,
STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,522,848 shares.
The largest 10 holders included
CAXTON CORP, NEA Management Company, LLC, ARMISTICE CAPITAL, LLC, Broadfin Capital, LLC, Park West Asset Management LLC, Opaleye Management Inc., Hudson Bay Capital Management LP, Prosight Management, LP, SPHERA FUNDS MANAGEMENT LTD., and 683 Capital Management, LLC.
This page lists
42
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.